COVID-19 and HME: What Next?
As COVID-19 vaccination rates increase, the HME industry is starting to anticipate what post-acute healthcare will look like going forward. Spiro Health’s Gary Sheehan offers his perspectives and insights.
- By David Kopf
- Mar 25, 2021
One segment of HME that has typified the entire industry’s experience with COVID-19 has been sleep therapy. Now that we are in the middle of the vaccine rollout, sleep providers — like all HME providers — are seeing some light at the end of the tunnel. What happens next?
In the current episode of the HMEB Podcast, Gary Sheehan, MBA, CEO of Spiro Health, who has shared his insights and perspectives during the pandemic, rejoins the podcast to discuss how sleep providers and the entire HME industry can transition into a post-pandemic reality and what that might look like.
Download the episode on iTunes, Stitcher, Google Podcasts, or listen to it here:
In the previous episode of the HMEB Podcast, Ty Bello, CEO of HME sales coaching and consulting firm Team@Work, explains why the new normal for HME sales will be grounded in market data and customer relationship management. He discusses how HME market data has grown will help HME sales teams grow existing referral sources and gain market share, as well as how they can leverage CRM for success. This episode was sponsored by PlayMaker Health.
The HMEB Podcast examines essential news, trends, and developments and interviews industry experts to find out how HME provider owners and operators can run efficient, profitable, and growing businesses with an eye on patient care. Make sure to subscribe on iTunes, Stitcher, or Google Podcasts, and start listening today!
About the Author
David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on LinkedIn at linkedin.com/in/dkopf/ and on Twitter at @postacutenews.